Serial Number | 87114868 |
Word Mark | A |
Filing Date | Monday, July 25, 2016 |
Status | 710 - CANCELLED - SECTION 8 |
Status Date | Friday, July 5, 2024 |
Registration Number | 5357644 |
Registration Date | Tuesday, December 19, 2017 |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, September 5, 2017 |
Description of Mark | The mark consists of the letter "a" appearing within a stylized border. |
Goods and Services | Pharmaceutical and veterinary preparations, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; sanitary preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; dietetic food and substances, namely, fermented milk products, drinks and gum, adapted for medical or veterinary use; dietary supplements for humans and animals; health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; disinfectants; preparations for destroying vermin; fungicides and herbicides; pharmaceuticals, biosimilars, medicine, drugs, namely, immunomodulators and anticancer agents, antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, for human beings and animals; prokaryotic organisms, namely, genetically modified bacteria, bacteria producing growth factors, antibodies, immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines; medicines for human purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; medicines for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; bacteriological preparations for medical and veterinary use, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; biological preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for medical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for pharmaceutical purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; chemical preparations for veterinary purposes, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer; pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, specifically autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors, namely, for tissue regeneration, treatment of chronic inflammatory diseases as well as autoimmune disorders and cancer |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 2 - Sec. 8 - Entire Registration |
Class Status Date | Friday, July 5, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Aurealis Pharma AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Basel 4058 CH |
Party Name | Aurealis Pharma AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Basel 4058 CH |
Party Name | Aurealis Pharma AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Basel 4058 CH |
Event Date | Event Description |
Thursday, July 28, 2016 | NEW APPLICATION ENTERED |
Thursday, July 28, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, July 29, 2016 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, November 3, 2016 | ASSIGNED TO EXAMINER |
Thursday, November 10, 2016 | NON-FINAL ACTION WRITTEN |
Thursday, November 10, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, November 10, 2016 | NON-FINAL ACTION E-MAILED |
Tuesday, May 9, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, May 9, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, May 12, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, May 15, 2017 | SUSPENSION LETTER WRITTEN |
Tuesday, September 5, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Monday, May 15, 2017 | LETTER OF SUSPENSION E-MAILED |
Monday, May 15, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, June 16, 2017 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Sunday, July 23, 2017 | ASSIGNED TO LIE |
Friday, July 28, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, July 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, July 28, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 16, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 5, 2017 | PUBLISHED FOR OPPOSITION |
Tuesday, December 19, 2017 | REGISTERED-PRINCIPAL REGISTER |
Monday, December 19, 2022 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Friday, July 5, 2024 | CANCELLED SEC. 8 (6-YR) |
Thursday, November 16, 2017 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
Tuesday, October 31, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Thursday, November 16, 2017 | NOTICE OF ALLOWANCE CANCELLED |